CAPR
Capricor Therapeutics Inc
8.70$
-7.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1,228.5% | – | – | – | – | – | – | – | -620.6% | – | – | |
| – | +164.6% | +13.4% | +14.7% | +9.3% | +9.1% | -16.3% | +70.8% | +117.0% | +100.5% | +33.3% | +32.5% | |
| – | +216.6% | +24.7% | -12.8% | +0.9% | -59.4% | +178.6% | +51.9% | +50.3% | +65.8% | +32.1% | +76.4% | |
| – | +216.6% | +120.1% | -50.6% | +0.9% | -59.2% | +177.5% | +42.6% | +61.3% | – | – | – | |
| – | -94.6% | -263.8% | – | – | – | – | -87.9% | +15,666.7% | -140.9% | – | – | |
| – | -18.9% | +28.1% | -83.4% | +883.3% | +73.0% | +0.0% | +118.5% | +180.8% | -39.1% | -24.8% | +88.7% | |
| – | -5,871.9% | -36.2% | – | -6.2% | -164.3% | – | -122.0% | +2,831.8% | – | -2,374.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +341,201.3% | -15.8% | -20.2% | -38.1% | -100.0% | – | -38.8% | -75.9% | – | – | – | |
| – | -8.7% | +0.0% | -89.5% | -36.4% | +0.0% | +0.0% | -100.0% | – | – | – | – | |
| – | +216.8% | +13.0% | -37.8% | -40.8% | +33.9% | +263.7% | -39.4% | -75.9% | +424.8% | +497.2% | +62.9% | |
| – | -139.1% | – | – | -200.3% | – | – | -92.3% | -1,239.1% | – | -166.9% | – | |
| – | -1,520.6% | – | – | – | – | – | – | – | -1,875.6% | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.